Participant flow

Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva · Source last updated 2021-12-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Gemcitabine 50 mg/m2 and Cisplatin 40mg/m2 administered weekly throughout IMRT radiation therapy. Gemcitabine will be infused prior to cisplatin and given over approximately 30 minutes while the cisplatin will be delivered over approximately 60 minutes.

   id

   FG000

   title

   GEM+CIS+IMRT

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         3

      type

      Never Treated

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Inadequate Pathology

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         57

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         53

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         4

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

GOG-0279 was activated on 07/02/2012 and closed to accrual on February 20, 2020.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice